Detalhe da pesquisa
1.
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma.
Breast Cancer Res Treat
; 204(3): 453-463, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180699
2.
Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients.
Breast Cancer Res Treat
; 200(3): 323-335, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37286891
3.
A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort study.
Cancer
; 128(10): 1913-1920, 2022 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35226357
4.
Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.
Jpn J Clin Oncol
; 51(3): 434-443, 2021 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420502
5.
Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.
Breast Cancer Res Treat
; 180(1): 97-110, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31989378
6.
Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
Breast Cancer Res Treat
; 178(2): 283-294, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402409
7.
Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
Breast Cancer Res Treat
; 173(2): 275-288, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30306430
8.
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03.
Breast Cancer Res Treat
; 171(3): 675-683, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29971625
9.
Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.
Ann Surg Oncol
; 25(9): 2603-2611, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29978372
10.
Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasis.
Histopathology
; 73(6): 916-922, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30035819
11.
Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.
Breast Cancer Res Treat
; 166(3): 709-723, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28831645
12.
Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab.
Oncology
; 93(1): 51-61, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28478451
13.
Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies.
Breast Cancer Res Treat
; 158(1): 1-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27260189
14.
Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.
Breast Cancer Res Treat
; 156(1): 45-55, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26943913
15.
Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.
Breast Cancer Res Treat
; 155(1): 65-75, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26715212
16.
An international study to increase concordance in Ki67 scoring.
Mod Pathol
; 28(6): 778-86, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25698062
17.
Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast.
Cancer Sci
; 105(11): 1503-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25230018
18.
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer.
Breast Cancer
; 31(1): 31-41, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37812303
19.
The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes.
Clin Breast Cancer
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38472058
20.
Using the DNA Integrity Number to Analyze DNA Quality in Specimens Collected from Liquid-Based Cytology after Fine-Needle Aspiration of Breast Tumors and Lesions.
Acta Cytol
; 68(2): 145-152, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38555634